Gender Male
Investor Type Number of Exits
Overview
Personal Investments
Announced Date | Organization Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|
 Navidea Biopharmaceuticals | Post-IPO Debt - Navidea Biopharmaceuticals | |||
Navidea Biopharmaceuticals | Post-IPO Equity - Navidea Biopharmaceuticals |
Exits
Navidea BiopharmaceuticalsNavidea develops precision immunodiagnostic agents and immunotherapeutics for patients with cancer, autoimmune, and infectious diseases.
